CompanyProfileNomu
Actions
Al-Modawat Specialized Medical Co.
- Nomu - Parallel Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 18.40
-
Open 18.20
-
High 18.20
-
Low 17.50
-
No. Of Trades 182
-
Avg. Trade size* 460
-
Volume Traded 83,722
-
Value Traded (^) 1,479,831.70
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Trade Updates
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select A Maximum Of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 01/09/2024 | 31/10/2024 | 14/11/2024 | Account Transfer | ^0.14 |
| 31/03/2024 | 09/06/2024 | 30/06/2024 | Account Transfer | ^7.00 |
CompanyProfileNomuv2Financials
Actions
- Announcements & Corporate Actions
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Semi-Annual
| Balance Sheet | 2024-12-31 | |||
|---|---|---|---|---|
| Total Assets |
117,552.5
|
- | - | - |
| Total Liabilities |
40,430.2
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
77,122.3
|
- | - | - |
| Total Liabilities and Shareholders Equity |
117,552.5
|
- | - | - |
| Statement of Income | 2024-12-31 | |||
| Total Revenue (Sales/Operating) |
75,487.7
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
6,790.4
|
- | - | - |
| Zakat and Income Tax |
-717.2
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
6,073.2
|
- | - | - |
| Total Comprehensive Income |
5,095.8
|
- | - | - |
| Profit (Loss) per Share |
0.26
|
- | - | - |
| Cash Flows | 2024-12-31 | |||
| Net Cash From Operating Activities |
10,066.9
|
- | - | - |
| Net Cash From Investing Activities |
-18,713.1
|
- | - | - |
| Net Cash From Financing Activities |
24,139.3
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
274.9
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
15,768
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | ^ | |||
| Last Update Date | 2025-04-03 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-06-30 | |||
|---|---|---|---|---|
| Total Assets |
116,443
|
- | - | - |
| Total Liabilities |
37,930.1
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
78,512.9
|
- | - | - |
| Total Liabilities and Shareholders Equity |
116,443
|
- | - | - |
| Statement of Income | 2024-06-30 | |||
| Total Revenue (Sales/Operating) |
37,287.8
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
3,934
|
- | - | - |
| Zakat and Income Tax |
-772.6
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
3,161.4
|
- | - | - |
| Total Comprehensive Income |
3,161.4
|
- | - | - |
| Profit (Loss) per Share |
0.14
|
- | - | - |
| Cash Flows | 2024-06-30 | |||
| Net Cash From Operating Activities |
2,244.9
|
- | - | - |
| Net Cash From Investing Activities |
3,306.7
|
- | - | - |
| Net Cash From Financing Activities |
30,032.5
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
274.8
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
24,755.7
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | ^ | |||
| Last Update Date | 2024-09-02 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The current actual activity of the company is managing the hospital affiliated with the company. The hospital specializes in various medical fields, including cardiology, orthopedics, neurology, obstetrics and gynecology, ophthalmology, dermatology clinic, gastroenterology clinic and endoscopy, internal medicine, pediatrics, psychiatry, general surgery, emergency medicine, otolaryngology (ear, nose, and throat), general dentistry, pulmonology, intensive care, urology, laboratory department, and diagnostic radiology department.
Company History
A Saudi joint stock company listed on 25/02/2024
Company Bylaws
Equity Profile
- Authorized Capital (^) 23,750,000
- Issued Shares 23,750,000
- Paid Up Capital (^) 23,750,000
- Par Value/Share 1
- Paid Up Value/Share 1
Last Update :2024-06-10
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Abdulaziz ibrahim mohamed alyahya
Company Address:
King Abdullah Bin Abdulaziz (3) PO Box 176, Postal Code 61913
Contact Details:
Telephone: 0172856666
Fax: 0172851265
Email: info@almodawat.sa
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}